Variant report

Variant	nsv1006545
Chromosome Location	chr2:212362134-212419865
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

TF binding
region (count:179)
CpG islands
(count:183)
Chromatin interactive
region (count:7)
LncRNA
region (count:0)
Mature miRNA
region (count: 0)
miRNA target
sites (count:0)

(count:179 , 50 per page) page: 1 2 3 4

No.	Transcrition factor	Chromosome Location	Cell Line	Cell type	Cell Stage	Matched TF binding sites
1	BACH1	chr2:212363692-212363815	H1-hESC	embryonic stem cell:	n/a	n/a
2	CEBPB	chr2:212375518-212375530	H1-hESC	embryonic stem cell:	n/a	n/a
3	CEBPB	chr2:212363646-212363764	HepG2	liver:	n/a	chr2:212363681-212363692
4	CEBPB	chr2:212372106-212372296	H1-hESC	embryonic stem cell:	n/a	n/a
5	CEBPB	chr2:212363575-212363885	H1-hESC	embryonic stem cell:	n/a	chr2:212363681-212363692
6	CEBPB	chr2:212377956-212378135	HepG2	liver:	n/a	chr2:212378026-212378037
7	CEBPB	chr2:212414722-212414939	HepG2	liver:	n/a	chr2:212414816-212414827
8	CHD2	chr2:212363638-212363823	H1-hESC	embryonic stem cell:	n/a	n/a
9	CTCF	chr2:212368680-212368830	HPAF	blood vessel:	n/a	n/a
10	CTCF	chr2:212368720-212368870	GM12869	blood:	n/a	n/a
11	CTCF	chr2:212368720-212368870	MCF-7	breast:	n/a	n/a
12	CTCF	chr2:212368700-212368850	GM12867	blood:	n/a	n/a
13	CTCF	chr2:212368720-212368870	HEK293	kidney:	n/a	n/a
14	CTCF	chr2:212368720-212368870	A549	lung:	n/a	n/a
15	CTCF	chr2:212368747-212368867	LNCaP	prostate:	n/a	n/a
16	CTCF	chr2:212368694-212368843	MCF-7	breast:	n/a	n/a
17	CTCF	chr2:212368700-212368850	GM12872	blood:	n/a	n/a
18	CTCF	chr2:212368660-212368810	GM12801	blood:	n/a	n/a
19	CTCF	chr2:212368620-212368770	HCT-116	colon:	n/a	n/a
20	CTCF	chr2:212368720-212368870	AG09309	skin:	n/a	n/a
21	CTCF	chr2:212368621-212368821	K562	blood:	n/a	n/a
22	CTCF	chr2:212368687-212368856	K562	blood:	n/a	n/a
23	CTCF	chr2:212368691-212368835	A549	lung:	n/a	n/a
24	CTCF	chr2:212368700-212368850	GM12865	blood:	n/a	n/a
25	CTCF	chr2:212368574-212368963	MCF-7	breast:	n/a	n/a
26	CTCF	chr2:212368700-212368850	HAc	cerebellar:	n/a	n/a
27	CTCF	chr2:212368691-212368854	HepG2	liver:	n/a	n/a
28	CTCF	chr2:212368640-212368790	K562	blood:	n/a	n/a
29	CTCF	chr2:212368740-212368890	HRE	kidney:	n/a	n/a
30	CTCF	chr2:212368320-212368470	GM12873	blood:	n/a	n/a
31	CTCF	chr2:212368620-212368770	NHEK	skin:	n/a	n/a
32	CTCF	chr2:212368720-212368870	SK-N-SH_RA	brain:	n/a	n/a
33	CTCF	chr2:212368660-212368810	HL-60	blood:	n/a	n/a
34	CTCF	chr2:212368681-212368872	GM19239	blood:	n/a	n/a
35	CTCF	chr2:212368720-212368870	NHEK	skin:	n/a	n/a
36	CTCF	chr2:212368675-212368892	Hela-S3	cervix:	n/a	n/a
37	CTCF	chr2:212368660-212368810	HMF	breast:	n/a	n/a
38	CTCF	chr2:212368600-212368750	NHDF-neo	bronchial:	n/a	n/a
39	CTCF	chr2:212368640-212368790	AoAF	blood vessel:	n/a	n/a
40	CTCF	chr2:212368700-212368850	GM12868	blood:	n/a	n/a
41	CTCF	chr2:212368620-212368770	HepG2	liver:	n/a	n/a
42	CTCF	chr2:212368720-212368870	GM12878	blood:	n/a	n/a
43	CTCF	chr2:212368694-212368835	LNCaP	prostate:	n/a	n/a
44	CTCF	chr2:212368740-212368890	HFF-Myc	foreskin:	n/a	n/a
45	CTCF	chr2:212368700-212368850	HRPEpiC	eye:	n/a	n/a
46	CTCF	chr2:212368680-212368830	GM12873	blood:	n/a	n/a
47	CTCF	chr2:212368596-212368939	GM12878	blood:	n/a	n/a
48	CTCF	chr2:212368700-212368850	HBMEC	blood vessel:	n/a	n/a
49	CTCF	chr2:212368640-212368790	GM12872	blood:	n/a	n/a
50	CTCF	chr2:212368720-212368870	GM06990	blood:	n/a	n/a

(count:183 , 50 per page) page: 1 2 3 4

No.	Chromosome Location	Cell Line	Cell type	Cell Stage
1	chr2:212389424-212389474	SK-N-MC	brain:	n/a
2	chr2:212363715-212363765	ovcar-3	ovarian:	n/a
3	chr2:212389424-212389474	T-47D	breast:	n/a
4	chr2:212388373-212388423	NHDF-neo	bronchial:	n/a
5	chr2:212363715-212363765	GM19239	blood:	n/a
6	chr2:212389424-212389474	HRCEpiC	kidney:	n/a
7	chr2:212363715-212363765	BE2_C	brain:	n/a
8	chr2:212389424-212389474	GM12892	blood:	n/a
9	chr2:212363715-212363765	HMEC	breast:	n/a
10	chr2:212389424-212389474	SK-N-SH_RA	brain:	n/a
11	chr2:212388373-212388423	HEEpiC	esophagus:	n/a
12	chr2:212389424-212389474	GM06990	blood:	n/a
13	chr2:212388373-212388423	BE2_C	brain:	n/a
14	chr2:212389424-212389474	AG09319	gingival:	n/a
15	chr2:212388373-212388423	ProgFib	skin:	n/a
16	chr2:212388373-212388423	T-47D	breast:	n/a
17	chr2:212363715-212363765	U87	brain:	n/a
18	chr2:212388373-212388423	HEK293	kidney:	embryo
19	chr2:212363715-212363765	ProgFib	skin:	n/a
20	chr2:212388373-212388423	H1-hESC	embryonic stem cell:	embryo
21	chr2:212389424-212389474	HCPEpiC	choroid plexus:	n/a
22	chr2:212388373-212388423	NHBE	bronchial:	n/a
23	chr2:212388373-212388423	Caco-2	colon:	n/a
24	chr2:212363715-212363765	HPAEpiC	pulmonary alveolar:	n/a
25	chr2:212363715-212363765	H1-hESC	embryonic stem cell:	embryo
26	chr2:212363715-212363765	AG04450	lung:	fetal
27	chr2:212388373-212388423	GM12891	blood:	n/a
28	chr2:212363715-212363765	AG09319	gingival:	n/a
29	chr2:212363715-212363765	HCM	heart:	n/a
30	chr2:212389424-212389474	HUVEC	blood vessel:	n/a
31	chr2:212389424-212389474	SKMC	muscle:	n/a
32	chr2:212389424-212389474	HIPEpiC	eye:	n/a
33	chr2:212363715-212363765	HUVEC	blood vessel:	n/a
34	chr2:212388373-212388423	Hela-S3	cervix:	n/a
35	chr2:212389424-212389474	HPAEpiC	pulmonary alveolar:	n/a
36	chr2:212389424-212389474	NHDF-neo	bronchial:	n/a
37	chr2:212389424-212389474	HAEpiC	amniotic membrane:	n/a
38	chr2:212389424-212389474	GM12878	blood:	n/a
39	chr2:212389424-212389474	GM19239	blood:	n/a
40	chr2:212389424-212389474	Hepatocyte	liver:	n/a
41	chr2:212388373-212388423	SK-N-SH_RA	brain:	n/a
42	chr2:212388373-212388423	SK-N-MC	brain:	n/a
43	chr2:212388373-212388423	K562	blood:	n/a
44	chr2:212388373-212388423	IMR90	lung:	fetal
45	chr2:212363715-212363765	HEEpiC	esophagus:	n/a
46	chr2:212363715-212363765	Hela-S3	cervix:	n/a
47	chr2:212389424-212389474	ProgFib	skin:	n/a
48	chr2:212389424-212389474	LNCaP	prostate:	n/a
49	chr2:212389424-212389474	GM12891	blood:	n/a
50	chr2:212388373-212388423	HUVEC	blood vessel:	n/a

(count:7 , 50 per page) page: 1

No.	Distal block	Cell Line	Cell type
1	chr2:212408584..212410240-chr2:212416395..212418822,2	MCF-7	breast:
2	chr2:212366946..212368723-chr2:212370212..212371913,2	K562	blood:
3	chr2:212288710..212290756-chr2:212380740..212383126,2	MCF-7	breast:
4	chr2:212320246..212322831-chr2:212376794..212379145,2	MCF-7	breast:
5	chr1:203274022..203274758-chr2:212363047..212363985,2	MCF-7	breast:
6	chr2:212408584..212410240-chr2:212416395..212418822,2	MCF-7	breast:
7	chr2:212366946..212368723-chr2:212370212..212371913,2	K562	blood:

No data

Variant related genes	Relation type
RNA5SP119	TF binding region
RNA5SP119	CpG island
ENSG00000159388	chromatin interactions
ENSG00000233791	chromatin interactions

Extended variants
information (count: 2518 )
Associated
traits (count: 68 )

Variant overlapped rSNPs/rCNVs (count:2518 , 50 per page) page: 1 2 3 4 5 6 7 ... 51

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs6751044	chr2:212362134-212362135	Weak transcription Enhancers	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
2	rs573360266	chr2:212362176-212362177	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
3	rs6751135	chr2:212362183-212362184	Weak transcription Enhancers	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
4	rs137932023	chr2:212362209-212362210	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
5	rs78248578	chr2:212362215-212362216	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
6	rs574550799	chr2:212362238-212362239	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
7	rs540190440	chr2:212362254-212362255	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
8	rs560410072	chr2:212362258-212362259	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
9	rs572737370	chr2:212362259-212362260	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
10	rs10932377	chr2:212362263-212362264	Weak transcription Enhancers	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
11	rs376591564	chr2:212362301-212362302	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
12	rs562106582	chr2:212362302-212362303	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
13	rs12620169	chr2:212362328-212362329	Weak transcription Enhancers	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
14	rs188235265	chr2:212362346-212362347	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
15	rs13005140	chr2:212362352-212362353	Weak transcription Enhancers	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
16	rs192524602	chr2:212362374-212362375	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
17	rs184548549	chr2:212362375-212362376	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
18	rs567173616	chr2:212362378-212362379	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
19	rs532812918	chr2:212362387-212362388	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
20	rs573161811	chr2:212362403-212362404	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
21	rs552643940	chr2:212362405-212362406	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
22	rs187479033	chr2:212362410-212362411	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
23	rs35355062	chr2:212362418-212362419	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
24	rs538367227	chr2:212362447-212362448	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
25	rs114869518	chr2:212362457-212362458	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
26	rs568424849	chr2:212362481-212362482	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
27	rs534016011	chr2:212362487-212362488	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
28	rs547164965	chr2:212362500-212362501	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
29	rs543995027	chr2:212362552-212362553	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
30	rs149050999	chr2:212362566-212362567	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
31	rs36076630	chr2:212362576-212362577	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
32	rs193285226	chr2:212362582-212362583	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
33	rs10932378	chr2:212362620-212362621	Weak transcription Enhancers	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
34	rs529403853	chr2:212362625-212362626	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
35	rs568489855	chr2:212362627-212362628	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
36	rs575611158	chr2:212362629-212362630	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
37	rs376371048	chr2:212362663-212362664	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
38	rs79360842	chr2:212362664-212362665	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
39	rs75246625	chr2:212362665-212362666	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
40	rs34672401	chr2:212362668-212362669	Weak transcription Enhancers	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
41	rs143079327	chr2:212362672-212362673	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
42	rs560659724	chr2:212362737-212362738	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
43	rs532901631	chr2:212362738-212362739	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
44	rs375716446	chr2:212362770-212362771	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
45	rs201661482	chr2:212362771-212362772	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
46	rs373713485	chr2:212362799-212362800	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
47	rs531745452	chr2:212362816-212362817	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
48	rs80000855	chr2:212362850-212362851	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
49	rs116116276	chr2:212362926-212362927	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
50	rs184619229	chr2:212362927-212362928	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a

Variant related diseases (count:68)

Disease	PMID	Source
Ewing''s sarcoma	21437220	CNVD
Glioblastoma multiforme	21080181	CNVD
Medulloblastoma	21979893	CNVD
Ependymoma	16718352	CNVD
Melanoma	18172304	CNVD
Cancer	16751803	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Acute lymphoblastic leukemia	20067559	CNVD
Acute lymphoblastic leukemia	21980252	CNVD
Breast cancer	17603634	CNVD
Testicular germ cell tumor	18059402	CNVD
Breast cancer	16272173	CNVD
Ewing''s sarcoma	17952124	CNVD
Cancer	21637783	CNVD
Non-syndromic sensorineural hearing loss	18471307	CNVD
Esophageal squamous carcinoma	21637470	CNVD
Liposarcoma	21253554	CNVD
Endometrial cancer	22040021	CNVD
Breast cancer	21264507	CNVD
Embryonal rhabdomyosarcoma	16790082	CNVD
Autism	16446308	CNVD
Autism	19401682	CNVD
Colorectal cancer	16272173	CNVD
Lung cancer	18438408	CNVD
Prostate cancer	18632612	CNVD
Acute myeloid leukemia	20729466	CNVD
small cell lung cancer	20016488	CNVD
Biliary cancer	20360734	CNVD
Breast cancer	20360734	CNVD
Coronary artery disease	20360734	CNVD
Crohn''s disease	20360734	CNVD
Hypertension	20360734	CNVD
Rheumatoid arthritis	20360734	CNVD
Type 1 diabetes	20360734	CNVD
Type 2 diabetes	20360734	CNVD
Urothelial carcinoma	21177765	CNVD
Hodgkin''s lymphoma	17606441	CNVD
Cervical cancer	21062161	CNVD
Adenoid cystic carcinoma	18698036	CNVD
Non-muscle invasive bladder neoplasm	19445696	CNVD
Non-small cell lung cancer	21829676	CNVD
Autism	20808228	CNVD
Renal cell carcinoma	18765545	CNVD
Ovarian cancer	19193619	CNVD
Non-small cell lung cancer	18676828	CNVD
Oral squamous cell carcinoma	17134496	CNVD
Myofibroblastic sarcoma	19369631	CNVD
Chordoma	18071362	CNVD
Myelofibrosis	22110671	CNVD
Schizophrenia	18923514	CNVD
Schizophrenia	22241247	CNVD
Non-syndromic sensorineural hearing loss	15273396	CNVD
Urothelial cell carcinoma	18451213	CNVD
Developmental delay	21147756	CNVD
Acute lymphoblastic leukemia	22237106	CNVD
Schizophrenia	20838587	CNVD
Breast cancer	17661082	CNVD
Breast cancer	20668451	CNVD
Cancer	20668451	CNVD
Lung cancer	20668451	CNVD
Ovarian cancer	20668451	CNVD
Pancreas cancer	20668451	CNVD
Prostate cancer	20668451	CNVD
Breast cancer	22522925	CNVD
Pancreatic cancer	17952125	CNVD
Schizophrenia	18990708	CNVD
Non-syndromic sensorineural hearing loss	21987784	CNVD
Non-syndromic sensorineural hearing loss	21293372	CNVD

Chromatin state (count:104 , 50 per page) page: 1 2 3

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr2:212352800-212362200	Weak transcription	hESC Derived CD184+ Endoderm Cultured Cells	ES cell derived
2	chr2:212353000-212363400	Weak transcription	H1 Derived Neuronal Progenitor Cultured Cells	ES cell derived
3	chr2:212359200-212363200	Weak transcription	HUES64 Cell Line	embryonic stem cell
4	chr2:212359400-212363200	Weak transcription	HUES48 Cell Line	embryonic stem cell
5	chr2:212362000-212365400	Enhancers	H9 Derived Neuron Cultured Cells	ES cell derived
6	chr2:212362200-212362800	Enhancers	hESC Derived CD184+ Endoderm Cultured Cells	ES cell derived
7	chr2:212362200-212364000	Enhancers	H9 Derived Neuronal Progenitor Cultured Cells	ES cell derived
8	chr2:212362600-212363800	Enhancers	Brain Angular Gyrus	brain
9	chr2:212362800-212363200	Enhancers	iPS-20b Cell Line	embryonic stem cell
10	chr2:212362800-212363800	Enhancers	Foreskin Melanocyte Primary Cells skin03	Skin
11	chr2:212362800-212363800	Enhancers	Brain Hippocampus Middle	brain
12	chr2:212362800-212368600	Weak transcription	hESC Derived CD184+ Endoderm Cultured Cells	ES cell derived
13	chr2:212363200-212363400	Enhancers	iPS-18 Cell Line	embryonic stem cell
14	chr2:212363200-212363800	Enhancers	HUES6 Cell Line	embryonic stem cell
15	chr2:212363200-212363800	Enhancers	HUES64 Cell Line	embryonic stem cell
16	chr2:212363200-212363800	Flanking Active TSS	iPS-20b Cell Line	embryonic stem cell
17	chr2:212363200-212364000	Enhancers	HUES48 Cell Line	embryonic stem cell
18	chr2:212363200-212364000	Enhancers	Cortex derived primary cultured neurospheres	brain
19	chr2:212363200-212364000	Enhancers	Brain Cingulate Gyrus	brain
20	chr2:212363200-212364000	Enhancers	Brain Substantia Nigra	brain
21	chr2:212363400-212363600	Enhancers	iPS DF 6.9 Cell Line	embryonic stem cell
22	chr2:212363400-212363800	Enhancers	H1 Derived Neuronal Progenitor Cultured Cells	ES cell derived
23	chr2:212363400-212363800	Flanking Active TSS	iPS-18 Cell Line	embryonic stem cell
24	chr2:212363400-212363800	Enhancers	Brain Inferior Temporal Lobe	brain
25	chr2:212363400-212363800	Enhancers	Brain Dorsolateral Prefrontal Cortex	brain
26	chr2:212363400-212364000	Enhancers	iPS-15b Cell Line	embryonic stem cell
27	chr2:212363600-212363800	Flanking Active TSS	iPS DF 6.9 Cell Line	embryonic stem cell
28	chr2:212363800-212364000	Enhancers	iPS-18 Cell Line	embryonic stem cell
29	chr2:212363800-212364000	Enhancers	iPS-20b Cell Line	embryonic stem cell
30	chr2:212364000-212364400	Weak transcription	H9 Derived Neuronal Progenitor Cultured Cells	ES cell derived
31	chr2:212364000-212364400	Weak transcription	iPS-15b Cell Line	embryonic stem cell
32	chr2:212364400-212364800	Enhancers	iPS-15b Cell Line	embryonic stem cell
33	chr2:212364400-212365200	Enhancers	H9 Derived Neuronal Progenitor Cultured Cells	ES cell derived
34	chr2:212364600-212365400	Enhancers	Fetal Heart	heart
35	chr2:212367800-212368200	ZNF genes & repeats	Aorta	Aorta
36	chr2:212368600-212368800	ZNF genes & repeats	H1 Derived Neuronal Progenitor Cultured Cells	ES cell derived
37	chr2:212368600-212369400	ZNF genes & repeats	hESC Derived CD184+ Endoderm Cultured Cells	ES cell derived
38	chr2:212369400-212377600	Weak transcription	hESC Derived CD184+ Endoderm Cultured Cells	ES cell derived
39	chr2:212374400-212375200	Enhancers	Foreskin Melanocyte Primary Cells skin03	Skin
40	chr2:212374400-212375200	Enhancers	Brain Substantia Nigra	brain
41	chr2:212374600-212375000	Enhancers	Brain Hippocampus Middle	brain
42	chr2:212374600-212377600	Enhancers	H9 Derived Neuron Cultured Cells	ES cell derived
43	chr2:212375000-212377400	Weak transcription	Brain Hippocampus Middle	brain
44	chr2:212376400-212377600	Enhancers	H9 Derived Neuronal Progenitor Cultured Cells	ES cell derived
45	chr2:212376800-212377800	Enhancers	HUES48 Cell Line	embryonic stem cell
46	chr2:212377000-212378400	Enhancers	HUES64 Cell Line	embryonic stem cell
47	chr2:212377400-212377600	Enhancers	Fetal Kidney	kidney
48	chr2:212377400-212377800	Enhancers	HUES6 Cell Line	embryonic stem cell
49	chr2:212377400-212377800	Enhancers	Brain Hippocampus Middle	brain
50	chr2:212377400-212378400	Enhancers	iPS-18 Cell Line	embryonic stem cell

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links